Skip to main content

Research Repository

Advanced Search

In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011

Hutchinson, John P.; Fogarty, Andrew W.; McKeever, Tricia M.; Hubbard, Richard B.

In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011 Thumbnail


Authors

John P. Hutchinson

ANDREW FOGARTY ANDREW.FOGARTY@NOTTINGHAM.AC.UK
Clinical Associate Professor & Reader in Clinical Epidemiology

TRICIA MCKEEVER tricia.mckeever@nottingham.ac.uk
Professor of Epidemiology and Medical Statistics

RICHARD HUBBARD richard.hubbard@nottingham.ac.uk
Blf/Gsk Professor of Epidemiological Resp Research



Abstract

Rationale: Surgical lung biopsy can help to determine a specific diagnosis in interstitial lung disease, but has associated risks. Most currently available mortality data are derived from case series and may not be generalizable to broader populations.

Objectives: We aimed to assess in-hospital mortality following surgical lung biopsy for interstitial lung disease in a national secondary care dataset from the United States.

Methods: Data were obtained from the 2000-2011 Nationwide Inpatient Sample. Cases were identified using International Classification of Diseases (ICD-9-CM) codes for interstitial lung disease and surgical lung biopsies. Lung resections and cases of lung cancer were excluded. Weighted data were used to estimate numbers of biopsies nationwide and in-hospital mortality, and multivariable logistic regression was used to adjust for sex, age, geographic region, co-morbidity, type of operation and provisional diagnosis.

Measurements and Main Results: We estimated there to be around 12,000 surgical lung biopsies performed annually for interstitial lung disease in the United States, two-thirds of which were performed electively. In-hospital mortality was 1.7% for elective procedures, but significantly higher for non-elective procedures (16.0%). Male sex, increasing age, increasing co-morbidity, open surgery and a provisional diagnosis of idiopathic pulmonary fibrosis or connective tissue disease related interstitial lung disease were risk factors for increased mortality.

Conclusions: In-hospital mortality following elective surgical lung biopsy for interstitial lung disease is just under 2%, but significantly higher for non-elective procedures. Identified risk factors for death should be taken into account when counselling patients on whether to pursue a histological diagnosis.

Citation

Hutchinson, J. P., Fogarty, A. W., McKeever, T. M., & Hubbard, R. B. (2016). In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011. American Journal of Respiratory and Critical Care Medicine, 193(10), 1161-1167. https://doi.org/10.1164/rccm.201508-1632OC

Journal Article Type Article
Acceptance Date Dec 8, 2015
Online Publication Date Dec 8, 2015
Publication Date May 15, 2016
Deposit Date Apr 19, 2016
Publicly Available Date Apr 19, 2016
Journal American Journal of Respiratory and Critical Care Medicine
Print ISSN 1073-449X
Electronic ISSN 1535-4970
Publisher American Thoracic Society
Peer Reviewed Peer Reviewed
Volume 193
Issue 10
Pages 1161-1167
DOI https://doi.org/10.1164/rccm.201508-1632OC
Keywords Interstitial lung disease, Mortality, Surgery
Public URL https://nottingham-repository.worktribe.com/output/789990
Publisher URL http://www.atsjournals.org/doi/10.1164/rccm.201508-1632OC
Additional Information Originally Published in:
John P Hutchinson, Andrew W Fogarty, Tricia M McKeever, and Richard B. Hubbard. In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011. American Journal of Respiratory and Critical Care Medicine 2015 ; Volume 193, issue 10, pages 1161-1167
DOI: 10.1164/rccm.201508-1632OC
Copyright © 2016 by the American Thoracic Society
The final publication is available at http://www.atsjournals.org/doi/10.1164/rccm.201508-1632OC

Files






You might also like



Downloadable Citations